Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R01 Clinical Trial Optional)
ID: 357088Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $500K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/357088

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-25-240.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a grant opportunity titled "Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R01 Clinical Trial Optional)" aimed at supporting research projects that evaluate policies related to tobacco, alcohol, and cannabis use in the United States. The initiative focuses on understanding how these policies impact substance use and secondhand exposure among populations experiencing health disparities, with an emphasis on community engagement to enhance cancer prevention efforts. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and government entities, with funding available up to $500,000 per year for a maximum of five years. Interested parties can find more information and application details at the NIH grants website, with the application deadline set for January 7, 2028.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-25-240-Full-Announcement.html
    PAR-25-240.html
    The National Institutes of Health (NIH) is offering a funding opportunity for research projects that evaluate policies concerning tobacco, alcohol, and cannabis in the U.S. The initiative aims to address health disparities in the use of these substances, particularly among vulnerable populations, and promote health equity. Applications for the Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R01 Clinical Trial Optional) grant should include community engagement to enhance cancer prevention efforts related to substance use and exposure. The grant supports studies analyzing how changes in policy influence substance use and can mitigate disparities. Eligible applicants include higher education institutions, nonprofits, and government entities, with a budget of up to $500,000 per year for five years. A special requirement is the Plan for Enhancing Diverse Perspectives (PEDP) to foster inclusivity during the research process. Key research topics involve examining comprehensive smoke-free policies, advertising restrictions, treatment coverage, and pricing interventions. The application process emphasizes collaborative efforts with community organizations to effectively address health disparities caused by tobacco, alcohol, and cannabis use. Successful proposals will undergo peer review and be assessed based on the scientific merit, community engagement, and the expected impact on health equity.
    Similar Opportunities
    Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R21 Clinical Trial Optional)" aimed at supporting policy research projects that investigate the impact of tobacco, alcohol, and cannabis policies on health disparities in the U.S. The initiative seeks exploratory research that engages community organizations to promote equity in cancer prevention by addressing substance use and exposure among disadvantaged populations. This grant program, with an estimated total funding of $200,000 and an award ceiling of $200,000, emphasizes the importance of community partnerships and diverse research team perspectives. Applications are due by January 7, 2028, and interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-25-241.html.
    Notice of Intent to Publish a Funding Opportunity Announcement for Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for research projects focused on health equity related to tobacco, alcohol, and cannabis policies. This initiative aims to address disparities in exposure and use of these substances by examining new or adapted policies in the U.S., with the goal of advancing equitable health policies. The funding opportunity will utilize the R01 grant mechanism, which is optional for clinical trials, and is expected to open for applications in February 2025, with a funding ceiling of $499,999. Interested applicants should prepare their proposals in advance, as the NOFO is anticipated to be published in September 2024, and further details, including a pre-application webinar, will be announced following the publication.
    Notice of Intent to Publish a Funding Opportunity Announcement for Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for pilot and exploratory research projects focused on health equity related to tobacco, alcohol, and cannabis use. The initiative aims to investigate disparities in exposure and usage of these substances by examining new or adapted policies in the U.S., with the goal of advancing equitable health policies. This funding opportunity will utilize the R21 grant mechanism, which supports early-stage research, and is expected to be published in September 2024, with the first application deadline in March 2025. Interested applicants should prepare their proposals in advance, as the estimated award date is December 1, 2025, and further details, including a pre-application webinar, will be announced following the NOFO publication.
    High-Priority Research in Tobacco Regulatory Science (Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "High-Priority Research in Tobacco Regulatory Science (Clinical Trial Optional)" aimed at supporting research that informs the FDA's tobacco regulatory authorities. This initiative seeks applications for high-priority research projects that address topics such as addiction, behavior, health effects, product composition, and toxicity, with the goal of enhancing the scientific data available for tobacco product regulation. The total estimated funding for this program is $7 million, with an award ceiling of $500,000 and an expected eight awards to be made. Interested applicants can reach out to Erik Rodriquez, Ph.D., M.P.H., at TRSP@nih.gov or by phone at 301-827-2830, with applications due by May 4, 2026, and awards expected to be announced by December 4, 2026.
    Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)" aimed at supporting interdisciplinary research to enhance public awareness and develop interventions that address the relationship between alcohol consumption and cancer risk. The initiative focuses on changing social norms, evaluating alcohol policy approaches, and implementing population-level interventions, particularly targeting underrepresented minority populations who experience disparities related to alcohol use and cancer. This funding opportunity is critical as alcohol is a significant preventable risk factor for various cancers, and traditional individual-level interventions have proven inadequate. Applications will be accepted starting January 5, 2025, with a maximum project period of five years, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. The application deadline is set for January 7, 2027.
    Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the "Population Approaches to Reducing Alcohol-related Cancer Risk" funding opportunity, designated as R01 Clinical Trial Optional. This initiative aims to support interdisciplinary research focused on increasing awareness of the link between alcohol consumption and cancer risk, altering social norms regarding alcohol use, evaluating alcohol policy approaches, and developing population-level interventions to mitigate alcohol-related cancer risks. The funding is particularly relevant for addressing alcohol use disorders and disparities faced by underrepresented minority populations, with applications due between January 5, 2024, and October 5, 2026, and project periods extending up to five years. There is no specific budget limit for applications, which should reflect the actual needs of the proposed projects. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-23-244.html.
    Alcohol Health Services Research (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the National Institute on Alcohol Abuse and Alcoholism (NIAAA) for the Alcohol Health Services Research (R01 Clinical Trial Optional) grant. This initiative aims to address the treatment gap for individuals with Alcohol Use Disorder (AUD) by focusing on five key areas: increasing access to treatment, enhancing the appeal of treatment, examining cost structures and insurance systems, studying the dissemination and implementation of evidence-based approaches, and reducing health disparities among affected populations. The grant allows for a maximum budget of $500,000 and a project period of up to five years, with applications due by September 7, 2026. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Tobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Tobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial Optional) to support early-stage researchers in tobacco regulatory science. This funding opportunity aims to facilitate small-scale projects that generate data to inform the U.S. Food and Drug Administration's (FDA) regulations on tobacco products, in alignment with the Family Smoking Prevention and Tobacco Control Act (FSPTCA). Eligible applicants include various organizations such as higher education institutions, non-profits, and government entities, with awards of up to $75,000 available for projects lasting up to two years, and a total funding pool of $500,000 anticipated for fiscal year 2026. Interested applicants should submit their proposals through Grants.gov and eRA Commons by the closing date of July 14, 2026, and can direct inquiries to grantsinfo@nih.gov for further information.
    Tobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing the upcoming Tobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial Optional), aimed at supporting high-priority research topics in tobacco regulatory science. This program seeks to fund innovative research that will provide scientific data to inform the FDA's regulatory authorities concerning tobacco products, particularly in relation to the Family Smoking Prevention and Tobacco Control Act (FSPTCA). With an estimated total funding of $500,000 and the expectation of awarding four grants, the Notice of Funding Opportunity (NOFO) is anticipated to be published in Fall 2025, with applications due in Winter 2026. For further inquiries, interested applicants can contact Erik Rodriquez, Ph.D., at TRSP@nih.gov or by phone at 301-827-2830.
    Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders" (R34 Clinical Trial Optional). This initiative encourages pilot studies aimed at preparing for larger-scale effectiveness trials that focus on optimizing access, quality, and affordability of substance use disorder treatments and related services, with an emphasis on diverse perspectives through a Plan for Enhancing Diverse Perspectives (PEDP). Applicants may request up to $450,000 in direct costs for a three-year grant, with application due dates beginning January 16, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-25-100.html.